Transcription of Model Standing Order and Immunization Protocol Template
{{id}} {{{paragraph}}}
IP COVID-19 vaccine Page 1 of 19 OHA 8285 (7/19) A. PUBLIC HEALTH DIVISION Immunization Program Immunization Protocol COVID-19 vaccine (Pfizer-BioNTech, Moderna, Janssen [Johnson & Johnson]) Last Reviewed 7 January 2022 Last Revised 7 January 2022 This Order expires 30 June 2022 Table of contents What s new .. 1 Oregon Immunization Protocol .. 2 vaccine schedule for COVID-19 vaccine .. 3 Licensed COVID-19 vaccine .. 4 Recommendations for use .. 5 Contraindications .. 6 Warnings and precautions .. 7 Other considerations .. 8 Side effects and adverse reactions .. 9 Storage and handling .. 9 Adverse events reporting .. 11 References .. 12 Appendix A .. 15 Appendix B .. 16 Appendix C .. 17 Appendix D .. 19 What s new CDC now recommends that all people 12 years of age receive a booster dose of Pfizer vaccine 5 months after completing their initial Pfizer vaccination The interval between the final dose in the primary series and the booster dose has been shortened to 5 months for the Moderna IP COVID-19 vaccine Page 2 of 19 Immunocompromised children 5 through 11 years old should receive a third dose of Pfizer vaccine 28 days after the previous ACIP recommends the use of Pfizer and Moderna mR
A. Check the ALERT Immunization Information System (IIS) to determine whether the patient needs this vaccine. If ALERT IIS is unavailable, use available documentation and patient statement. B. Screen client for contraindications and precautions. C. Provide a Vaccine Information Fact Sheet for Recipients and Caregivers , and answer any questions.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}